Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Cervical Cancer
100%
Radiation Therapy
88%
Neoplasm
76%
Pelvis
60%
Positron Emission Tomography
57%
Carcinoma
55%
Brachytherapy
46%
Diseases
43%
Chemotherapy
35%
Recurrent Disease
32%
Tumor
31%
Fluorodeoxyglucose
29%
Cervix
29%
Uterine Cervix
26%
Overall Survival
26%
Fluorodeoxyglucose F 18
25%
Lymph Node
24%
Uterine Cervix Carcinoma
24%
Polyethylene Terephthalate
23%
Positron Emission Tomography-Computed Tomography
22%
Treatment Planning
22%
Intensity Modulated Radiation Therapy
20%
Uterine Cancer
18%
Prognostic Factor
17%
Cancer
16%
Disease Free Survival
16%
Chemoradiotherapy
16%
Magnetic Resonance Imaging
15%
Oncology
15%
Drug Megadose
14%
Paraaortic Lymph Node
14%
Progression Free Survival
14%
External Beam Radiotherapy
13%
Distant Metastasis
13%
Malignant Neoplasm
13%
Computer Assisted Tomography
12%
Endometrium Carcinoma
12%
Lymph Node Metastasis
12%
Clinical Stage
10%
Pelvic Radiotherapy
10%
Implant
10%
Dose Distribution
9%
Cisplatin
9%
Radiation Oncology
9%
Radical Hysterectomy
9%
High-Dose-Rate Brachytherapy
9%
Histology
8%
Multivariate Analysis
8%
Metastatic Carcinoma
8%
Low Drug Dose
8%
Keyphrases
Cervical Cancer
85%
Cervical Carcinoma
56%
Irradiation
49%
Tumor
45%
Brachytherapy
33%
Positron Emission Tomography/computed Tomography (PET/CT)
33%
Radiation Therapy
33%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
30%
Radiotherapy
26%
Overall Survival
22%
Prognostic Factors
19%
Chemotherapy
18%
Distant Metastasis
15%
Progression-free Survival
15%
Stage IB
13%
Disease-free Survival
13%
Pelvis
13%
Concurrent Chemotherapy
13%
Endometrial Cancer
11%
Intracavitary
11%
HDR Brachytherapy
11%
Intensity-modulated Radiation Therapy
11%
Radiation Therapy Oncology Group
11%
Stage IIA
10%
Para-aortic Lymph Node
10%
Cervical Cancer Patients
9%
Pelvic Lymph Nodes
9%
Radical Hysterectomy
9%
Tumor Volume
9%
Cervical Cancer Prevention
9%
Interstitial Brachytherapy
9%
Radiation Dose
9%
Multivariate Analysis
8%
High Dose
8%
Cisplatin
8%
Radiation Oncology
8%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
8%
Endometrial Carcinoma
8%
Tumor Control
8%
Tumor Size
8%
Cervix
8%
SUVmax
8%
Invasive Cervical Cancer
7%
External Irradiation
7%
Fluorodeoxyglucose
7%
Fluorodeoxyglucose Uptake
7%
Chemoradiation
7%
Local Control
7%
Recurrent Disease
7%
Postoperative Irradiation
7%